Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator?
Fisher
Marc
M
Department of Neurology, University of Massachusetts Medical School, Worcester, MA.
D001921:Brain / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology*; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D038524:Diffusion Magnetic Resonance Imaging; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator